<DOC>
	<DOC>NCT02224014</DOC>
	<brief_summary>Study to investigate the safety and the efficacy in patients with insomnia, receiving Lendormin D tablet under condition of normal clinical practice.</brief_summary>
	<brief_title>Lendormin DÂ® Tablet (Drug Use Result Survey)</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Brotizolam</mesh_term>
	<criteria>Patients with insomnia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>